pharmaceuticals-and-healthcare

Global Antibody-drug Conjugates Market Research Report 2017


Published On : Aug 2017

Category : Pharmaceutical

No. of Pages : 101 pages

  • $2900
  • $5800

SPECIFY YOUR RESEARCH NEED

  • Query Type :
  •  
Table of Contents

Global Antibody-drug Conjugates Market Research Report 2017
1 Antibody-drug Conjugates Market Overview
1.1 Product Overview and Scope of Antibody-drug Conjugates
1.2 Antibody-drug Conjugates Segment by Type (Product Category)
1.2.1 Global Antibody-drug Conjugates Production and CAGR (%) Comparison by Type (Product Category) (2012-2022)
1.2.2 Global Antibody-drug Conjugates Production Market Share by Type (Product Category) in 2016
1.2.3 Seattle Genetics technology
1.2.4 ImmunoGen technology
1.2.5 Immunomedics technology
1.3 Global Antibody-drug Conjugates Segment by Application
1.3.1 Antibody-drug Conjugates Consumption (Sales) Comparison by Application (2012-2022)
1.3.2 IgG1 antibodies
1.3.3 HER2 antibodies
1.4 Global Antibody-drug Conjugates Market by Region (2012-2022)
1.4.1 Global Antibody-drug Conjugates Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
1.4.2 North America Status and Prospect (2012-2022)
1.4.3 Europe Status and Prospect (2012-2022)
1.4.4 China Status and Prospect (2012-2022)
1.4.5 Japan Status and Prospect (2012-2022)
1.4.6 Southeast Asia Status and Prospect (2012-2022)
1.4.7 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value) of Antibody-drug Conjugates (2012-2022)
1.5.1 Global Antibody-drug Conjugates Revenue Status and Outlook (2012-2022)
1.5.2 Global Antibody-drug Conjugates Capacity, Production Status and Outlook (2012-2022)

2 Global Antibody-drug Conjugates Market Competition by Manufacturers
2.1 Global Antibody-drug Conjugates Capacity, Production and Share by Manufacturers (2012-2017)
2.1.1 Global Antibody-drug Conjugates Capacity and Share by Manufacturers (2012-2017)
2.1.2 Global Antibody-drug Conjugates Production and Share by Manufacturers (2012-2017)
2.2 Global Antibody-drug Conjugates Revenue and Share by Manufacturers (2012-2017)
2.3 Global Antibody-drug Conjugates Average Price by Manufacturers (2012-2017)
2.4 Manufacturers Antibody-drug Conjugates Manufacturing Base Distribution, Sales Area and Product Type
2.5 Antibody-drug Conjugates Market Competitive Situation and Trends
2.5.1 Antibody-drug Conjugates Market Concentration Rate
2.5.2 Antibody-drug Conjugates Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Antibody-drug Conjugates Capacity, Production, Revenue (Value) by Region (2012-2017)
3.1 Global Antibody-drug Conjugates Capacity and Market Share by Region (2012-2017)
3.2 Global Antibody-drug Conjugates Production and Market Share by Region (2012-2017)
3.3 Global Antibody-drug Conjugates Revenue (Value) and Market Share by Region (2012-2017)
3.4 Global Antibody-drug Conjugates Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.5 North America Antibody-drug Conjugates Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.6 Europe Antibody-drug Conjugates Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.7 China Antibody-drug Conjugates Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.8 Japan Antibody-drug Conjugates Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.9 Southeast Asia Antibody-drug Conjugates Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.10 India Antibody-drug Conjugates Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 Global Antibody-drug Conjugates Supply (Production), Consumption, Export, Import by Region (2012-2017)
4.1 Global Antibody-drug Conjugates Consumption by Region (2012-2017)
4.2 North America Antibody-drug Conjugates Production, Consumption, Export, Import (2012-2017)
4.3 Europe Antibody-drug Conjugates Production, Consumption, Export, Import (2012-2017)
4.4 China Antibody-drug Conjugates Production, Consumption, Export, Import (2012-2017)
4.5 Japan Antibody-drug Conjugates Production, Consumption, Export, Import (2012-2017)
4.6 Southeast Asia Antibody-drug Conjugates Production, Consumption, Export, Import (2012-2017)
4.7 India Antibody-drug Conjugates Production, Consumption, Export, Import (2012-2017)

5 Global Antibody-drug Conjugates Production, Revenue (Value), Price Trend by Type
5.1 Global Antibody-drug Conjugates Production and Market Share by Type (2012-2017)
5.2 Global Antibody-drug Conjugates Revenue and Market Share by Type (2012-2017)
5.3 Global Antibody-drug Conjugates Price by Type (2012-2017)
5.4 Global Antibody-drug Conjugates Production Growth by Type (2012-2017)

6 Global Antibody-drug Conjugates Market Analysis by Application
6.1 Global Antibody-drug Conjugates Consumption and Market Share by Application (2012-2017)
6.2 Global Antibody-drug Conjugates Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets-Countries

7 Global Antibody-drug Conjugates Manufacturers Profiles-Analysis
7.1 F. Hoffmann-La Roche
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2 Antibody-drug Conjugates Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 F. Hoffmann-La Roche Antibody-drug Conjugates Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.1.4 Main Business-Business Overview
7.2 Seattle Genetics
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.2.2 Antibody-drug Conjugates Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 Seattle Genetics Antibody-drug Conjugates Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.2.4 Main Business-Business Overview
7.3 Takeda Pharmaceuticals
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.3.2 Antibody-drug Conjugates Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 Takeda Pharmaceuticals Antibody-drug Conjugates Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.3.4 Main Business-Business Overview
7.4 AbbVie
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.4.2 Antibody-drug Conjugates Product Category, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
7.4.3 AbbVie Antibody-drug Conjugates Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.4.4 Main Business-Business Overview
7.5 AbGenomics
7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.5.2 Antibody-drug Conjugates Product Category, Application and Specification
7.5.2.1 Product A
7.5.2.2 Product B
7.5.3 AbGenomics Antibody-drug Conjugates Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.5.4 Main Business-Business Overview
7.6 ADC Therapeutics
7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.6.2 Antibody-drug Conjugates Product Category, Application and Specification
7.6.2.1 Product A
7.6.2.2 Product B
7.6.3 ADC Therapeutics Antibody-drug Conjugates Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.6.4 Main Business-Business Overview
7.7 Agensys
7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.7.2 Antibody-drug Conjugates Product Category, Application and Specification
7.7.2.1 Product A
7.7.2.2 Product B
7.7.3 Agensys Antibody-drug Conjugates Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.7.4 Main Business-Business Overview
7.8 ALMAC Group
7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.8.2 Antibody-drug Conjugates Product Category, Application and Specification
7.8.2.1 Product A
7.8.2.2 Product B
7.8.3 ALMAC Group Antibody-drug Conjugates Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.8.4 Main Business-Business Overview
7.9 Ambrx
7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.9.2 Antibody-drug Conjugates Product Category, Application and Specification
7.9.2.1 Product A
7.9.2.2 Product B
7.9.3 Ambrx Antibody-drug Conjugates Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.9.4 Main Business-Business Overview
7.10 Astellas Pharma
7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.10.2 Antibody-drug Conjugates Product Category, Application and Specification
7.10.2.1 Product A
7.10.2.2 Product B
7.10.3 Astellas Pharma Antibody-drug Conjugates Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.10.4 Main Business-Business Overview

8 Antibody-drug Conjugates Manufacturing Cost Analysis
8.1 Antibody-drug Conjugates Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Antibody-drug Conjugates

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Antibody-drug Conjugates Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Antibody-drug Conjugates Major Manufacturers in 2015
9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors-Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors-Traders List

11 Market Effect Factors Analysis
11.1 Technology Progress-Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs-Customer Preference Change
11.3 Economic-Political Environmental Change

12 Global Antibody-drug Conjugates Market Forecast (2017-2022)
12.1 Global Antibody-drug Conjugates Capacity, Production, Revenue Forecast (2017-2022)
12.1.1 Global Antibody-drug Conjugates Capacity, Production and Growth Rate Forecast (2017-2022)
12.1.2 Global Antibody-drug Conjugates Revenue and Growth Rate Forecast (2017-2022)
12.1.3 Global Antibody-drug Conjugates Price and Trend Forecast (2017-2022)
12.2 Global Antibody-drug Conjugates Production, Consumption , Import and Export Forecast by Region (2017-2022)
12.2.1 North America Antibody-drug Conjugates Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.2 Europe Antibody-drug Conjugates Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.3 China Antibody-drug Conjugates Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.4 Japan Antibody-drug Conjugates Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.5 Southeast Asia Antibody-drug Conjugates Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.6 India Antibody-drug Conjugates Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.3 Global Antibody-drug Conjugates Production, Revenue and Price Forecast by Type (2017-2022)
12.4 Global Antibody-drug Conjugates Consumption Forecast by Application (2017-2022)

13 Research Findings and Conclusion

14 Appendix
14.1 Methodology-Research Approach
14.1.1 Research Programs-Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer


Back To Top